Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
NCT ID: NCT01010048
Last Updated: 2009-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
120 participants
INTERVENTIONAL
2009-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus
NCT01215708
Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis
NCT00762424
Medical Expulsive Therapy Post-SWL For Renal Stones
NCT05032287
Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones
NCT04819828
Comparative Study Between Tadalafil Versus Tamsulosin as a Medical Expulsive Therapy for Lower Ureteric Stones
NCT04641507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
progesterone,tamsulosin,propantheline Bromide and nifedipine
different effect of these drugs use to treat urinary calculus after ESWL
progesterone,tamsulosin,propantheline Bromide and nifedipine
clearance rate of stone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
progesterone,tamsulosin,propantheline Bromide and nifedipine
clearance rate of stone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* urinary calculus could be treated by ESWL,
* the calculus size is from 4-25mm
Exclusion Criteria
* the calculus size is from Less than4 or larger than 25mm
18 Years
68 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The First Affiliated Hospital ,Chongqing Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
xiaohou wu, doctor
Role: STUDY_CHAIR
First Affiliated Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital, ChongQing medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Yunfeng He, Doctor
Role: CONTACT
Xiaohou Wu, Doctor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yunfeng He, Doctor
Role: primary
Xiaohou Wu, Doctor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CQMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.